William Makis (makisw.substack.com), 2026-09-21: Paid Substack post asserting that six clinical trials of ivermectin in cancer now exist; the body is behind a paywall and could not be read.
William Makis (makisw.substack.com), 2026-09-21: Paid Substack post asserting that six clinical trials of ivermectin in cancer now exist; the body is behind a paywall and could not be read. C4. Record field: the title is transcribed exactly as published ('There are now 6 Clinical Trials Examining the use of Ivermectin in Cancer!'), not a quotation from the body. The post is marked 'Paid' and the body was not accessible; the six trials are not identifiable from the free portion. For comparison, this run's registry sweep found the following cancer-directed ivermectin trials: NCT05318469, NCT07487805, CTRI/2026/09/118358, ACTRN12623001164684 and (COVID-in-cancer, not antitumour) NCT04447235, plus two supportive-care or multi-drug registrations (NCT07895498, NCT02366884) – see C1 rows. His count cannot be verified without the paywalled list.
